Aseptic Processing & Annex 1 Training Course
无菌工艺及欧盟GMP附录1 主题沙龙
Aseptic Processing & Annex 1 (T63) – New Course!
无菌工艺和欧盟GMP附录1(T63)- 新沙龙!
Overview概述
Driven by biopharmaceuticals but also prominent in small molecules drug manufacturing as well as for APIs, aseptic processing will undergo a technology jump start driven by the new EC GMP Guide Annex 1. Globally supplying companies, which deliver drugs to Europe, must comply with this new regulatory requirement. There is an impact for all stakeholders of manufacturing, across hierarchy levels and various functions at manufacturers. Also, suppliers have to consider Annex 1 when supplying new equipment or installing new production facilities.
不仅源于生物制药的推动,且在小分子药物和原料药生产方面也很有优势的无菌工艺将在新的欧盟GMP指南附录1的推动下经历一次技术飞跃。向欧洲供应药品的全球的制药公司必须遵守这一新的监管要求。其对制药业的所有利益相关者都有影响,影响更是跨越制药公司的层级和各种职能。此外,制药公司在采用新设备或建设新的生产设施时,必须考虑欧盟GMP附录1。
This course will focus on aseptic processing and quality management around the most important pharmaceutical technology.
本课程将围绕最重要的制药技术,重点介绍无菌工艺和质量管理。
What You Will Learn你将学到什么
完成本课程后,您将能够:
了解新的欧盟GMP指南附录1及其对未来无菌工艺的影响
确定药品生产和环境控制的现行行业标准
参与监管机构检查中的关键话题讨论
Resources and Activities资源和活动
Course Modules课程模块
Who Should Attend谁应该参加